Castle Biosciences (CSTL) Financials

$32.76

$-0.15 (-0.46%)

As on 08-Sep-2026 16:29EDT

Market cap

$1,005 Mln

Revenue (TTM)

$357 Mln

P/E Ratio

--

P/B Ratio

2.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	357.28	344.23	332.07	219.79	137.04	94.09
Cost of Revenue	81.25	71.03	60.21	44.98	32.01	15.82
Gross Profit	276.03	273.20	271.86	174.81	105.03	78.26
Operating Expenses	308.13	316.01	263.19	242.78	177.89	118.34
Operating Profit (EBIT)	-32.11	-42.81	8.67	-67.98	-72.86	-40.08
Other Income	--	--	--	--	--	--
Profit before Tax	-19.20	-29.51	21.56	-57.37	-68.90	-40.01
Provision for Tax	0.21	-5.36	3.32	0.10	-1.77	-8.72
Profit after Tax (Net Income)	-19.42	-24.16	18.25	-57.47	-67.14	-31.29
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-67.14	-31.29

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	470.03	470.87	455.84	391.27	399.15	411.74
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	34.64	39.01	26.01	14.40	12.05	25.95
Current Liabilities	56.51	68.68	49.39	47.67	36.13	24.89
Total Liabilities	617.69	578.56	531.24	453.34	447.33	462.57

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	220.08	217.46	171.08	157.71	155.04	108.83
Current Assets	341.10	361.10	360.15	295.64	292.29	353.74
Total Assets	617.69	578.56	531.24	453.34	447.33	462.57
Total Debt*	36.65	36.91	26.34	15.34	13.40	8.20
Net Current Assets	284.59	292.42	310.76	247.97	256.16	328.86

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	64.35	64.87	-5.63	-41.66	-18.98
Cash Flow from Investing Activities	--	-60.37	-50.14	-16.18	-166.55	-66.66
Cash from Financing Activities	--	-6.96	6.14	-2.30	1.52	5.42
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.65	-0.82	0.60	-2.12	-2.54	-1.24
Cash EPS ($)	--	0.57	1.13	-1.68	-2.14	-1.10
Adjusted Book Value ($)	--	16.05	15.09	14.41	15.12	16.26
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	2.19	2.15	-0.21	-1.58	-0.75
Free Cash Flow per Share ($)	--	0.97	1.21	-0.71	-1.79	-0.89

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-4.88	4.11	-14.03	-16.13	-7.49
ROE (%)	-4.13	-5.21	4.31	-14.54	-16.56	-7.56
ROA (%)	-3.20	-4.35	3.71	-12.76	-14.76	-6.94
EBIT Margin (%)	-5.27	-8.55	6.67	-26.10	-50.27	-42.53
Net Margin (%)	-5.43	-7.02	5.49	-26.15	-48.99	-33.26
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	3.18	0.04	0.51	0.60	0.46	0.50
EBIT Growth (%)	-89.87	-232.91	138.60	16.74	-72.17	-428.83
Net Profit Growth (%)	-105.10	-232.41	131.75	14.41	-114.55	-204.28
EPS Growth (%)	-82.85	-2.36	1.29	0.17	-1.06	-1.50
Book Value Growth (%)	0.32	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-47.23	44.11	-10.19	-9.26	-34.70
Price / Book Value	2.17	2.42	1.77	1.50	1.56	2.64
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	42.95	77.45	14.11	-7.95	-6.45	-20.88
Close Price ($)	23.85	38.90	26.65	21.58	23.54	42.87
High Price ($)	44.28	42.18	35.84	29.59	48.40	107.69
Low Price ($)	14.59	14.59	16.97	9.26	15.58	37.99
Market Cap ($ Cr)	1,005.38	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.02	0.08	0.06	0.04	0.03	0.02
Short term debt to equity ratio	0.01	0.00	0.00	0.00	0.00	0.00
Current Ratio	6.04	5.26	7.29	6.20	8.09	14.21
Quick Ratio	5.85	5.11	7.13	6.04	7.98	14.13
Interest Coverage	-50.21	-342.19	38.37	-5,214.00	-4,052.18	-40,011.00

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	13.53	12.60	15.42	17.43	17.13	18.37
Asset Turnover	0.59	0.62	0.67	0.49	0.30	0.21
Receivable days	--	50.19	49.23	51.33	54.32	58.31
Inventory Days	--	47.28	48.77	48.40	34.24	48.92
Payable days	--	65.85	52.08	60.90	41.52	53.60
Cash Conversion Cycle	--	31.62	45.92	38.84	47.04	53.63

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.